Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis Elson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell ImagingLewis Elson, Amelie Tjaden, Stefan Knapp, et al.
Communications Chemistry|February 3, 2025
Chemogenomics for steroid hormone receptors (NR3)Espen Schallmayer, Laura Isigkeit, Lewis Elson, et al.
ACS Chemical Biology|January 3, 2025
Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein DegradationMartin P Schwalm, Amelie Menge, Lewis Elson, et al.
Nature Communications|June 18, 2024
Chemogenomics for NR1 nuclear hormone receptorsLaura Isigkeit, Espen Schallmayer, Romy Busch, et al.
European Journal of Medicinal Chemistry|July 27, 2024
Synthesis and evaluation of chemical linchpins for highly selective CK2α targetingFrancesco A Greco, Andreas Krämer, Laurenz Wahl, et al.
ACS Chemical Biology|December 8, 2025
Overcoming Ligand Discovery Challenges: Developing Peptide-Based Tracers for SPSB2Christopher Lenz, Lewis Elson, Johannes Dopfer, et al.
International Journal of Molecular Sciences|December 11, 2022
Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE FamilyJennifer Alisa Amrhein, Lena Marie Berger, Amelie Tjaden, et al.
Journal of Medicinal Chemistry|December 16, 2024
Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping ExamplePascal Sander, Martin P Schwalm, Andreas Krämer, et al.
ACS Chemical Biology|June 13, 2026
p21-Activated Kinase (PAK) Group I-Targeting Inhibitors Promote the Dimeric Conformation in Live CellsTheresa A L Ehret, Benedict-Tilman Berger, Nicolai Raig, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell ImagingLewis Elson, Amelie Tjaden, Stefan Knapp, et al.
Communications Chemistry|February 3, 2025
Chemogenomics for steroid hormone receptors (NR3)Espen Schallmayer, Laura Isigkeit, Lewis Elson, et al.
ACS Chemical Biology|January 3, 2025
Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein DegradationMartin P Schwalm, Amelie Menge, Lewis Elson, et al.
Nature Communications|June 18, 2024
Chemogenomics for NR1 nuclear hormone receptorsLaura Isigkeit, Espen Schallmayer, Romy Busch, et al.
European Journal of Medicinal Chemistry|July 27, 2024
Synthesis and evaluation of chemical linchpins for highly selective CK2α targetingFrancesco A Greco, Andreas Krämer, Laurenz Wahl, et al.
ACS Chemical Biology|December 8, 2025
Overcoming Ligand Discovery Challenges: Developing Peptide-Based Tracers for SPSB2Christopher Lenz, Lewis Elson, Johannes Dopfer, et al.
International Journal of Molecular Sciences|December 11, 2022
Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE FamilyJennifer Alisa Amrhein, Lena Marie Berger, Amelie Tjaden, et al.
Journal of Medicinal Chemistry|December 16, 2024
Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping ExamplePascal Sander, Martin P Schwalm, Andreas Krämer, et al.
ACS Chemical Biology|June 13, 2026
p21-Activated Kinase (PAK) Group I-Targeting Inhibitors Promote the Dimeric Conformation in Live CellsTheresa A L Ehret, Benedict-Tilman Berger, Nicolai Raig, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Pageof 3